TABLE 5.
Enhancing stem cell function by modulating the injury microenvironment.
| Biomaterial | Cell/tissue type | Observed effect | References |
|---|---|---|---|
| TGF-β-loaded Layer-by-layer scaffolds | Islets | Cell survival ↑ | Liu et al. (2016b) |
| Inflammatory cytokines (e.g., TNF-α, IL-12, MCP-1) ↓ | |||
| Leukocytes ↓ | |||
| Poly (vinyl alcohol) microneedle patch | CSCs | Paracrine factors secretion ↑ | Tang et al., 2020 |
| Scar tissue ↓ | |||
| Blood vessel regeneration ↑ | |||
| PEG-maleimide hydrogels | MSCs | ROS scavenging ↑ | Martin et al. (2020) |
| Cell survival ↑ | |||
| Immuno-protective device eluting alanine and glutamine | Islets | Cell survival ↑ | Chendke et al. (2019) |
| Immuno-protection of cells ↑ | |||
| Hydrogels encapsulating tacrolimus-eluting PLGA NPs | EPCs | Cell survival ↑ | Li et al. (2018) |
| Blood perfusion ↑ | |||
| Self-assembling peptides based hydrogels containing laminin-derived IKVAV motif | ESCs-derived cortical progenitors | Neuronal function ↑ | Somaa et al. (2017) |
| Motor function ↑ |
TGF-β, transforming growth factor beta; PEG, poly(ethylene glycol); PLGA, poly(L-lactide-co-glycolide); NPs, nanoparticles; CSCs, cardiac stem cells; ESCs, embryonic stem cells; MSCs, mesenchymal stem cells; EPCs, endothelial progenitor cells; TNF-α, tumor necrosis factor alpha; MCP-1, monocyte chemoattractant protein 1; IL-12, interleukin 12.